Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Related Articles


Article icon
Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy

Ryan Wallace, Hugh Calkins,


Citation: Arrhythmia & Electrophysiology Review 2021;10(1):26–32.

Sacubitril/Valsartan: Milestone in HFrEF Treatment

Mauro Gori, James L Januzzi, Emilia D’Elia,


Citation: Cardiac Failure Review 2021;7:e06.

Abstract: Right Ventricular Energetic Efficiency Improvement During Left…

Taro Kariya,


Citation: Interventional Cardiology Review 2021;16(Suppl 2):20–1.

Abstract: Impella RP Versus Pharmacological Vasoactive Treatment in…

Jakob Josiassen,


Citation: Interventional Cardiology Review 2021;16(Suppl 2):20.